Master dataINID | Criterion | Field | Content |
---|
| Type of IP right | SART | Patent |
| Status | ST | Not pending/lapsed |
21 | DE file number | DAKZ | 699 24 651.2 |
96 | EP file number | EAKZ | 03 07 7251.1 |
97 | EP publication number | EPN | 1361223 |
54 | Designation/title | TI | Verfahren zu Herstellung von 1,3-Oxathiolane Nukleosiden |
51 | IPC main class | ICM (ICMV) | C07D 327/04 (2006.01) |
51 | IPC secondary class(es) | ICS (ICSV) | C07D 411/04 (2006.01), C07D 473/00 (2006.01), A61K 31/505 (2006.01) |
22 | DE application date | DAT | Aug 12, 1999 |
96 | EP application date | EAT | Aug 12, 1999 |
43 | Date of first publication | OT | Nov 12, 2003 |
| Date of publication of grant | PET | Apr 6, 2005 |
71/73 | Applicant/owner | INH | Gilead Sciences, Inc., 94404 Foster City, Calif., US; Emory University, Atlanta, Ga., US |
72 | Inventor | IN | Cleary, Darryl, Chapel Hill, US; Soria, Jose, Decatur, US; Painter, George R., Chapel Hill, US; Liotta, Dennis C., McDonough, US; Almond, Merrick, Apex, US; Sznaidman, Marcos Luis, Durham, US |
| Address for service | | Carpmaels & Ransford, LONDON WC1A 2RA, GB |
33 31 32
| Foreign priority | PRC PRNA PRDA
| US 96214 P Aug 12, 1998
|
33 31 32
| Foreign priority | PRC PRNA PRDA
| US 122841 P Mar 4, 1999
|
| Patent division in charge | | 44 |
97 | EP language of publication | ELANG | EN - Englisch |
84 | Designated EP contracting states | EDS | AT, BE, CH, CY, DE, DK, ES, FI, FR, GB, GR, IE, IT, LI, LU, MC, NL, PT, SE |
43 | Date of first publication | EVT | Nov 12, 2003 |
| Date of the first transfer into DPMAregister | EREGT | Sep 29, 2012 |
| Date of the (most recent) update in DPMAregister | REGT | Oct 23, 2015 (Show all update days)(Hide all update days)- Oct 23, 2015; Jan 25, 2013
- Historical data not available for this/these date(s)
- Sep 29, 2012
- Date of the first transfer into DPMAregister
|
View procedures New applicant/owner details (No.: 4)INID | Criterion | Field | Content
Close details
|
---|
| Type of procedure | VART | New applicant/owner details |
| Legal/procedural status | VST | New applicant/owner details |
| Date of legal/procedural status | VSTT | Mar 3, 2005 |
71/73 | Applicant/owner | INH | Gilead Sciences, Inc., 94404 Foster City, Calif., US; Emory University, Atlanta, Ga., US |
71/73 | Previous applicant/owner | INHF | Triangle Pharmaceuticals Inc., Durham, N.C., US, Emory University, Atlanta, Ga., US |